TFThomas Fryer

Thomas Fryer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thomas Fryer has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Multiobjective V H H discovery through integrated high-throughput screening and AlphaFold3-guided structural prioritization

    by Max D. Overath, Suthimon Thumtecho, Esperanza Rivera-De-Torre, Melisa Benard-Valle, Darian S. Wolff, Rahmat Grahadi, Kasper H. Björnsson, Andreas S. H. Rygaard, Nils Hofmann, Jann Ledergerber, et al.

    Finding therapeutic antibodies that bind multiple related targets with high affinity and favorable biophysical properties remains challenging and resource-intensive. For snakebite antivenoms, this challenge is critical as treatments must neutralize toxins across multiple snake species. We developed a pipeline combining high-throughput yeast screening, deep sequencing, and AlphaFold3 structure prediction to identify polyspecific variable domains of heavy chain–only antibodies (V H Hs) against long-chain α-neurotoxins. Multiplexed yeast display screening generated a dataset of diverse hits with varying binding specificities. AlphaFold3-generated V H H-toxin complex predictions enabled stringent high-precision structural triage of polyspecific V H Hs that bind conserved epitopes across multiple toxins, with a representative subset experimentally confirmed to block toxin binding to the acetylcholine receptor. These structural insights provided a starting point for computational optimization of affinity and soluble expression of the V H Hs, with experimental validation confirming that optimized V H H variants maintained broad binding specificity across toxins. This integrated approach supports structure-guided prioritization of polyspecific V H H hits, offering a high-precision filter that could reduce future reliance on extensive experimental specificity screening and providing a framework applicable to other therapeutic contexts, in which substantial antigen variation occurs and broad neutralization is essential.


  • Open Access

    pH-sensitive binder design with Proton-PottsMPNN

    by Christian P. Jacobsen, Lukas Deweid, Foster Birnbaum, Line Gormsen, Thomas Fryer, Ulla Jagd, Andreas Hald, Morten Rasch, Timothy Jenkins, Sergey Ovchinnikov

    Physiological compartments span a wide pH range, from blood plasma near pH 7.4 through the mildly acidic tumor microenvironment to the acidified endosome and lysosome, and binders whose affinity responds to these differences underpin recycling antibodies, catalytic extracellular degraders and tumor-conditional therapeutics. Such binders are still obtained mainly by combinatorial histidine scanning and display selection, which is laborious and yields few transferable design rules. Recent computational approaches have enabled the design of pH-sensitive binders that engage at physiological pH and release under acidic conditions, by introducing histidines at key positions so that protonation generates electrostatic repulsion, evaluated through physics-based calculations. However, because the design model has no explicit representation of protonation state, it cannot shape the residues around a titratable site to favor one state over the other, leaving pH sensitivity to be screened for rather than specified. Here we present Proton-PottsMPNN, a sequence-design model that explicitly represents the protonated and deprotonated states of histidine, aspartate and glutamate as distinct sequence tokens. Because protonation state is specified rather than inferred, the model redesigns the microenvironment around a titratable residue so that the chosen protonation state is energetically favored over its alternative. Using Proton-PottsMPNN we designed a library of 8,407 de novo PD-L1 candidate binders in which sequence-structure compatibility and protonation state preference were designed jointly under a single energy function, with no structure-prediction filtering applied. The full library was synthesized and displayed on yeast, then screened against PD-L1 across a series of pH values by fluorescence- and magnetic-activated cell sorting, recovering 237 and 288 unique pH-dependent designs respectively. Transition pH values spanned 4.0 to 5.8, and switches were centered on protonated aspartate and glutamate as well as histidine. Recovered designs showed a stronger model preference for their designed protonation state than designs from the same backbone that were not recovered, and this preference was strongest in the designs that required the most acidic conditions to bind. Proton-PottsMPNN therefore designs binders that engage PD-L1 under acidic conditions fully de novo, directly from a specified protonation state.


  • Open Access

    Accelerating multi-objective V H H discovery via integrated high-throughput selection and AlphaFold3-guided structure prediction

    by Max D. Overath, Suthimon Thumtecho, Esperanza Rivera-De-Torre, Melisa Bénard-Valle, Darian S. Wolff, Rahmat Grahadi, Kasper H. Björnsson, Andreas S.H. Rygaard, Nils Hofmann, Jann Ledergerber, et al.

    Discovering therapeutic antibodies that bind multiple related targets with high affinity and favourable biophysical properties remains challenging and resource intensive. For snakebite antivenoms, this challenge is critical as treatments must neutralise toxins across multiple snake species. We developed a pipeline combining high-throughput yeast screening, deep sequencing, and AlphaFold3 structure prediction to rapidly identify poly-specific variable domains of heavy-chain-only antibodies (V H Hs) against long-chain α-neurotoxins. Multiplexed yeast display screening generated a dataset of diverse candidates with varying binding specificities. AlphaFold3-generated V H H-toxin complex predictions enabled structure-based prioritisation that accurately predicted poly-specific binders targeting conserved epitopes across multiple toxins. These structural insights enabled computational optimisation of both affinity and solubility without disrupting target recognition. Experimental validation confirmed improved variants maintained broad specificity across toxins. This integrated approach accelerates multi-objective antibody discovery by predicting which candidates will bind multiple targets before extensive laboratory testing, providing a generalisable strategy applicable beyond antivenoms to any therapeutic requiring broad target coverage.


  • Open Access

    Post-assembly Plasmid Amplification for Increased Transformation Yields in E. coli and S. cerevisiae

    by Thomas Fryer, Darian S. Wolff, Max D. Overath, Elena Schäfer, Andreas H. Laustsen, Timothy P. Jenkins, Carsten Andersen

    Many biological disciplines rely upon the transformation of host cells with heterologous DNA to edit, engineer, or examine biological phenotypes. Transformation of model cell strains (Escherichia coli) under model conditions (electroporation of circular supercoiled plasmid DNA; typically pUC19) can achieve >1010 transformants/μg DNA. Yet outside of these conditions, e.g., work with relaxed plasmid DNA from in vitro assembly reactions (cloned DNA) or nonmodel organisms, the efficiency of transformation can drop by multiple orders of magnitude. Overcoming these inefficiencies requires cost- and time-intensive processes, such as generating large quantities of appropriately formatted input DNA or transforming many aliquots of cells in parallel. We sought to simplify the generation of large quantities of appropriately formatted input cloned DNA by using rolling circle amplification (RCA) and treatment with specific endonucleases to generate an efficiently transformable linear DNA product for in vivo circularization in host cells. We achieved an over 6500-fold increase in the yield of input DNA, and demonstrate that the use of a nicking endonuclease to generate homologous single-stranded ends increases the efficiency of E. coli chemical transformation compared to both linear DNA with double-stranded homologous ends and circular Golden-Gate assembly products. Meanwhile, the use of a restriction endonuclease to generate linear DNA with double-stranded homologous ends increases the efficiency of chemical and electrotransformation of Saccharomyces cerevisiae. Importantly, we also optimized the process such that both RCA and endonuclease treatment occur efficiently in the same buffer, streamlining the workflow and reducing product loss through purification steps. We expect that our approach could have utility beyond E. coli and S. cerevisiae and be applicable to areas such as directed evolution, genome engineering, and the manipulation of alternative organisms with even poorer transformation efficiencies.


  • Open Access

    V-ToCs (Venom Toxin Clustering): A tool for the investigation of sequence and structure similarities in snake venom toxins

    by Konstantinos Kalogeropoulos, Vlad Rosca, Carol O'BRien, Charlotte Risager Christensen, Rahmat Grahadi, Christoffer Vinther Sørensen, Max D. Overath, Diego Ruiz Espi, David E. Jenkins, Ulrich Auf Dem Keller, et al.

  • Open Access

    A comparative study of protein structure prediction tools for challenging targets: Snake venom toxins

    by Konstantinos Kalogeropoulos, Markus-Frederik Bohn, David E. Jenkins, Jann Ledergerber, Christoffer V. Sørensen, Nils Hofmann, Jack Wade, Thomas Fryer, Giang Thi Tuyet Nguyen, Ulrich Auf Dem Keller, et al.


  • Open Access

    Simplified post-assembly plasmid library amplification for increased transformation yields in E. coli and S. cerevisiae

    by Thomas Fryer, Darian S. Wolff, Max D. Overath, Elena Schaefer, Andreas Hougaard Laustsen, Timothy P. Jenkins, Carsten Andersen

    Many biological disciplines rely upon the transformation of host cells with heterologous DNA, the limited efficiency of which can significantly hinder a researcher’s work. Directed evolution in particular typically requires the screening of large (thousand-billion member) libraries to identify sequences of interest, and the creation of these libraries at large enough scales to overcome transformation inefficiencies is a cost-and time-intensive process. We simplify this process by using Rolling Circle Amplification (RCA) to amplify in vitro plasmid DNA assembly reactions, followed by facile resolution of the concatomeric products to monomers through treatment with specific endonucleases and subsequent efficient transformation of the linear DNA products into host cells for in vivo circularisation. We demonstrate that use of a nicking endonuclease to generate homologous single-stranded ends increases the efficiency of E. coli chemical transformation versus both linear DNA with double-stranded homologous ends, and circular golden-gate assembly products, whilst use of a restriction endonuclease to generate linear DNA with double-stranded homologous ends increases the efficiency of chemical and electrotransformation of S. cerevisiae . Importantly, we also optimise the process such that both RCA and endonuclease treatment occur efficiently in the same buffer, streamlining the workflow and reducing product loss through purification steps. We expect our approach to have utility beyond directed evolution in E. coli and S. cerevisiae , to areas such as genome engineering and the manipulation of alternative organisms with even poorer transformation efficiencies.


  • Open Access

    A Comparative Study of Protein Structure Prediction Tools for Challenging Targets: Snake Venom Toxins

    by Konstantinos Kalogeropoulos, Markus-Frederik Bohn, David E. Jenkins, Jann Ledergerber, Christoffer V. Sørensen, Nils Hofmann, Jack Wade, Thomas Fryer, Giang Thi Tuyet Nguyen, Ullrich Auf Dem Keller, et al.

    Protein structure determination is a critical aspect of biological research, enabling us to understand protein function and potential applications. Recent advances in deep learning and artificial intelligence have led to the development of several protein structure prediction tools, such as AlphaFold2 and ColabFold. However, their performance has primarily been evaluated on well-characterised proteins, and comparisons using proteins with poor reference templates are lacking. In this study, we evaluated three modelling tools on their prediction of over 1000 snake venom toxin structures with no reference templates. Our findings show that AlphaFold2 (AF2) performed the best across all assessed parameters. We also observed that ColabFold (CF) only scored slightly worse than AF2, while being computationally less intensive. All tools struggled with regions of intrinsic disorder, such as loops and propeptide regions, and performed well in predicting the structure of functional domains. Overall, our study highlights the importance of exercising caution when working with proteins that have poor reference templates, are large, and contain flexible regions. Nonetheless, leveraging computational structure prediction tools can provide valuable insights into the modelling of protein interactions with different targets and reveal potential binding sites, active sites, and conformational changes, as well as into the design of potential molecular binders for reagent, diagnostic, or therapeutic purposes. Statement Recent advances in machine learning have led to the development of new protein structure prediction tools. However, these tools have mainly been tested on well-known proteins and their performance on proteins without known templates is unclear. This study evaluated the performance of three tools on over 1000 snake venom toxins. We found that while caution is required when studying poorly characterised proteins, these tools offer valuable opportunities to understand protein function and applications.


  • Open Access

    Gigavalent Display of Proteins on Monodisperse Polyacrylamide Hydrogels as a Versatile Modular Platform for Functional Assays and Protein Engineering

    by Thomas Fryer, Joel David Rogers, Christopher Mellor, Timo N. Kohler, Ralph Minter, Florian Hollfelder

    The assembly of robust, modular biological components into complex functional systems is central to synthetic biology. Here, we apply modular "plug and play" design principles to a solid-phase protein display system that facilitates protein purification and functional assays. Specifically, we capture proteins on polyacrylamide hydrogel display beads (PHD beads) made in microfluidic droplet generators. These monodisperse PHD beads are decorated with predefined amounts of anchors, methacrylate-PEG-benzylguanine (BG) and methacrylate-PEG-chloroalkane (CA), that react covalently with SNAP-/Halo-tag fusion proteins, respectively, in a specific, orthogonal, and stable fashion. Anchors, and thus proteins, are distributed throughout the entire bead volume, allowing attachment of ∼109 protein molecules per bead (⌀ 20 μm) -a higher density than achievable with commercial surface-modified beads. We showcase a diverse array of protein modules that enable the secondary capture of proteins, either noncovalently (IgG and SUMO-tag) or covalently (SpyCatcher, SpyTag, SnpCatcher, and SnpTag), in mono- and multivalent display formats. Solid-phase protein binding and enzymatic assays are carried out, and incorporating the photocleavable protein PhoCl enables the controlled release of modules via visible-light irradiation for functional assays in solution. We utilize photocleavage for valency engineering of an anti-TRAIL-R1 scFv, enhancing its apoptosis-inducing potency ∼50-fold through pentamerization.


  • Open Access

    Gigavalent display of proteins on monodisperse polyacrylamide hydrogels as a versatile modular platform for functional assays and protein engineering

    by Thomas Fryer, Joel David Rogers, Christopher Mellor, Ralph Minter, Florian Hollfelder

    The robust modularity of biological components that are assembled into complex functional systems is central to synthetic biology. Here we apply modular “plug and play” design principles to a microscale solid phase protein display system that enables protein purification and functional assays for biotherapeutics. Specifically, we capture protein molecules from cell lysates on polyacrylamide hydrogel display beads (‘PHD beads’), made in microfluidic droplet generators. These monodisperse PHD beads are decorated with predefined amounts of anchors, methacrylate-PEG-benzylguanine (BG) and methacrylate-PEG-chloroalkane (CA). Anchors form covalent bonds with fusion proteins bearing cognate tag recognition (SNAP and Halo-tags) in specific, orthogonal and stable fashion. Given that these anchors are copolymerised throughout the 3D structure of the beads, proteins are also distributed across the entire bead sphere, allowing attachment of ∼10 9 protein molecules per bead (Ø 20 μ m). This mode of attachment reaches a higher density than possible on widely used surface-modified beads, and additionally mitigates surface effects that often complicate studies with proteins on beads. We showcase a diverse array of protein modules that enable the secondary capture of proteins, either non-covalently (IgG and SUMO-tag) or covalently (SpyCatcher, SpyTag, SnpCatcher and SnpTag). Proteins can be displayed in their monomeric forms, but also reformatted as a multivalent display (using secondary capture modules that create branches) to test the contributions of avidity and multivalency towards protein function. Finally, controlled release of modules by irradiation of light is achieved by incorporating the photocleavable protein PhoCl: irradiation severs the displayed protein from the solid support, so that functional assays can be carried out in solution. As a demonstration of the utility of valency engineering, an antibody drug screen is performed, in which an anti-TRAIL-R1 scFv protein is released into solution as monomers-hexamers, showing a ∼50-fold enhanced potency in the pentavalent format. The ease of protein purification on solid support, quantitative control over presentation and release of proteins and choice of valency make this experimental format a versatile, modular platform for large scale functional analysis of proteins, in bioassays of protein-protein interactions, enzymatic catalysis and bacteriolysis. Table of Contents Graphics: